Annexon ANNX
Annexon, Inc. · Nasdaq · Pharmaceutical Preparations
$4.04+7.45%close on Oct. 28, 2026 · volume 4.0M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Sept. 24, 2026 | Douglas Love PRESIDENT AND CEO, director | Bought | 26,065 | $3.83 | $99,829 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 9 →Results of operations and financial condition · Other events · Financial statements and exhibits
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
Other events · Financial statements and exhibits
Entry into a material definitive agreement · Creation of a direct financial obligation · Other events · Financial statements and exhibits